Study on individualized antithrombotic therapy for high-risk groups-A feasibility study on the clinical prognosis of patients with coronary heart disease and diabetes mellitus

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800015104

Enrollment

Unknown

Registered

2018-03-07

Start date

2018-03-10

Completion date

Unknown

Last updated

2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

1:Aspirin + clopidogrel

2:aspirin + tiglielot

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years, diagnosed as unstable angina and diabetes; 2. Coronary artery stenting after admission; 3. Voluntary participation, signed informed consent.

Exclusion criteria

Exclusion criteria: 1. There are taboos and allergies to treatment. For example, in the first month, there were major surgical procedures, bleeding quality or coagulation disorder, hemoglobin <100g/L; 2. Severe liver and renal insufficiency or life expectancy <1 year. 3. The type and diagnosis of cases do not meet the diagnostic criteria; 4. Participated in other clinical trials in the last 3 months; 5. Evidence shows that the patient is untrustworthy; 6. The researcher considers that it is not suitable to participate in any other conditions of the experiment.

Design outcomes

Primary

Measure	Time frame
Platelet function;	—

Countries

China

Contacts

Public ContactJun Jin

Department of Cardiology,The Second Affiliated Hospital of Army Medical University

jjxqyy@163.com+86 023-68755601

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026